← All forecasts · November 2–6

VST / FQ3 2026 (quarter ended 2026-09-30)

Vistra Corp.

Reported: Nov 6, 2026

Forecast published

Opus 5.5 High in Shortcut

Review incomplete

Shortcut

2.58

Normalized diluted EPS

-16.4% vs Street

Off by $0.67 per share

Street

3.08

Normalized diluted EPS

November 1 consensus snapshot

Off by $0.17 per share

Real

3.25

Reported normalized EPS

Street win

Reported result · Nov 6 ↗ · Provider reports Q3 2026 normalized EPS of $3.25.

USD per diluted ordinary/common share. Comparisons use unrounded estimates.

Model download

Explore the assumptions and calculations behind the forecast. This is the agent’s original workbook. Its review didn’t finish, so it hasn’t been checked or repaired.

Shortcut’s reasoning.

Ongoing Adj. EBITDA modelled at $2,125m (Street $2,110-2,173m per Raymond James/BofA previews); built Y/Y by segment: Texas +$208m (Martin Lake return, gas margins, less 3Q25 PTC catch-up), East +$294m (Lotus, PJM capacity $329/MW-day), Retail +$45m.

Mapping EBITDA to the consensus normalized basis (less D&A incl. ~$122m nuclear fuel amortization, ~$308m interest, 23% tax and $47m preferred dividends) gives $2.58 on 337.6m diluted shares — this bridge reproduced consensus normalized actuals within $0.10 in 3Q25, 1Q26 and 2Q26 but missed 4Q25 by +$0.64 (consensus above model), the main upside risk.

Consensus $3.08 (4 estimates, low $2.72) appears to exclude nuclear-fuel amortization and preferred dividends (EBITDA $2,142m - D&A $498m - interest $301m, taxed at 23% = $1,042m with no preferred deduction), so the consensus data-computed actual is likely to land below it unless EBITDA exceeds ~$2.35bn.

2026 guidance ($6.8-7.6bn, 'at or above midpoint') implies 2H26 of ~$3.94bn; 3Q26E is ~54% of that, above the 42-48% seasonal share of 2024-25, so no upward adjustment to the Street EBITDA anchor.

Revenue $5.34bn is volume x price by segment (retail GWh x $/MWh; generation TWh x realized $/MWh) with zero unrealized hedging revenue; consensus revenue has overshot reported revenue in 5 of the last 6 quarters as hedging MTM sits in revenue.

Cohort prior 0.78 (S&P 500, $46bn market cap) and 1 beat in 6 gives a 0.52 starting probability; lowered to 0.18 for the modelled -$0.50 gap to consensus.

On the record.

Reporting period
FQ3 2026 (quarter ended 2026-09-30)
Reporting basis
consensus normalized diluted EPS, USD per diluted common share (GAAP net income to common excl. unrealized commodity/interest-rate hedging MTM, transition & merger costs, impairments, insurance gains and NDT/decommissioning items, tax-effected at 23%, after preferred dividends)
Consensus snapshot
November 1, 2026
Model / effort
Opus 5.5 · High effort
Workbook
Original workbook · review incomplete
Record history
Forecast generated
Nov 1, 2026 at 11:23 PM PST
First posted
Nov 2, 2026 at 4:10 PM PST
Result checked
Nov 6, 2026 at 11:36 AM PST
Result basis

Provider reports Q3 2026 normalized EPS of $3.25. All six frozen normalized historical EPS values match. The issuer confirms the quarter and reports net income and adjusted EBITDA; it does not publish a normalized EPS reconciliation in this release. It is scored on the provider’s normalized EPS, the same basis as the Street.